These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine. Hashimoto T; Harusawa S; Araki L; Zuiderveld OP; Smit MJ; Imazu T; Takashima S; Yamamoto Y; Sakamoto Y; Kurihara T; Leurs R; Bakker RA; Yamatodani A J Med Chem; 2003 Jul; 46(14):3162-5. PubMed ID: 12825954 [TBL] [Abstract][Full Text] [Related]
5. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure. Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 4(5)-(5-aminotetrahydropyran-2-yl)imidazole derivatives and their in vivo release of neuronal histamine measured by brain microdialysis. Harusawa S; Kawamura M; Araki L; Taniguchi R; Yoneyama H; Sakamoto Y; Kaneko N; Nakao Y; Hatano K; Fujita T; Yamamoto R; Kurihara T; Yamatodani A Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1245-53. PubMed ID: 17666853 [TBL] [Abstract][Full Text] [Related]
7. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands. Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145 [TBL] [Abstract][Full Text] [Related]
8. Efficient and beta-Stereoselective Synthesis of 4(5)-(beta-D-Ribofuranosyl)- and 4(5)-(2-Deoxyribofuranosyl)imidazoles(1). Harusawa S; Murai Y; Moriyama H; Imazu T; Ohishi H; Yoneda R; Kurihara T J Org Chem; 1996 Jun; 61(13):4405-4411. PubMed ID: 11667345 [TBL] [Abstract][Full Text] [Related]
9. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone. Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands. Geyer R; Kaske M; Baumeister P; Buschauer A Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592 [TBL] [Abstract][Full Text] [Related]
12. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies. Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267 [TBL] [Abstract][Full Text] [Related]
13. Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. Łazewska D; Wiecek M; Ligneau X; Kottke T; Weizel L; Seifert R; Schunack W; Stark H; Kieć-Kononowicz K Bioorg Med Chem Lett; 2009 Dec; 19(23):6682-5. PubMed ID: 19846299 [TBL] [Abstract][Full Text] [Related]
14. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists. Geyer R; Nordemann U; Strasser A; Wittmann HJ; Buschauer A J Med Chem; 2016 Apr; 59(7):3452-70. PubMed ID: 27007611 [TBL] [Abstract][Full Text] [Related]
15. Development of versatile cis- and trans-dicarbon-substituted chiral cyclopropane units: synthesis of (1S,2R)- and (1R,2R)-2-aminomethyl-1-(1H-imidazol-4-yl)cyclopropanes and their enantiomers as conformationally restricted analogues of histamine. Kazuta Y; Matsuda A; Shuto S J Org Chem; 2002 Mar; 67(5):1669-77. PubMed ID: 11871901 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of histamine H Watanabe M; Kobayashi T; Ito Y; Fukuda H; Yamada S; Arisawa M; Shuto S Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3630-3633. PubMed ID: 30385161 [TBL] [Abstract][Full Text] [Related]
17. Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations. Reher TM; Neumann D; Buschauer A; Seifert R Biochem Pharmacol; 2012 Jul; 84(2):192-203. PubMed ID: 22516788 [TBL] [Abstract][Full Text] [Related]
18. Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity. Wijtmans M; de Graaf C; de Kloe G; Istyastono EP; Smit J; Lim H; Boonnak R; Nijmeijer S; Smits RA; Jongejan A; Zuiderveld O; de Esch IJ; Leurs R J Med Chem; 2011 Mar; 54(6):1693-703. PubMed ID: 21348462 [TBL] [Abstract][Full Text] [Related]
19. 1-[(2,3-Dihydro-1-benzofuran-2-yl) methyl]piperazines as novel anti-inflammatory compounds: Synthesis and evaluation on H Corrêa MF; Varela MT; Balbino AM; Torrecilhas AC; Landgraf RG; Troncone LRP; Fernandes JPDS Chem Biol Drug Des; 2017 Aug; 90(2):317-322. PubMed ID: 28109127 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives. Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]